The document summarizes an interim report for SCA for Q3 2012. It found that sales increased 16% due to acquisitions in tissue and strong growth in emerging markets, particularly for personal care and tissue products. EBIT increased 20% due to acquisitions, higher volumes, lower raw material costs, and cost savings. However, forest products faced lower demand and prices in European markets. Overall the hygiene business saw good sales growth and profitability while forest products faced challenging market conditions.
SCA’s profit before tax, excluding restructuring costs, rose 9% (12% excluding exchange rate effects) to SEK 6,218m (5,724). Net sales decreased by 2% (excluding exchange rate effects, increased by 4%) to SEK 81,578m (83,350). Profit for the period, excluding restructuring costs, rose 10% to SEK 4,601m (4,179).
http://www.sca.com
Net sales increased by 1% (4% excl exchange rate effects and divestments) to SEK 19,490m (19,231). Operating profit excl items affecting comparability rose 4% (7% excl divestments) to SEK 1,834m (1,767). Earnings per share amounted to SEK 1.73 (1.89). Cash flow from current operations was SEK 1,301m (446).
Read more on http://www.sca.com/Q12012en
Net sales rose 11% excl. exchange rate effects and divestments to SEK 85,408m (81,337). Operating profit increased to SEK 8,646m (7,738). Operating cash flow was SEK 9,644m (7,418). Earnings per share were SEK 7.06 (0.78). The Board of Directors proposes an increase in the dividend by 7.1%, to SEK 4.50 per share (4.20).
Operating profit, excluding items affecting comparability, decreased by 4% (unchanged excluding exchange rate effects) to SEK 9,224m (9,608). The Board of Directors proposes an increase in the dividend by 5%, to SEK 4.20 (4.00) per share. Net sales decreased by 1% (increased by 4% excluding exchange rate effects and divestments) to SEK 105,750m (106,965).
Read more on http://www.sca.com/Q42011en
http://www.sca.com/Q32011en SCA’s interim report for the period 1 January – 30 September 2011 has been published. Operating profit , excl. restructuring costs, decreased by 5% (decreased by 1% excl. exchange rate effects) to SEK 6,697m. Net sales decreased by 1% (increased by 6% excl. exchange rate effects and divestments) to SEK 79 001m. Earnings per share rose 2% (7% excl. exchange rate effects) to SEK 5.66.
http://www.sca.com/ir
http://www.facebook.com/SCA
http://www.twitter.com/SCAeveryday
http://www.youtube.com/SCAeveryday
Net sales decreased by 3 percent to SEK 54,374m. Profit before tax rose 12% to SEK 3,944m. Restructuring costs amounted to SEK 451m. Profit for the period rose 10% to 2,860m. Earnings per share were SEK 3.57. Cash flow from current operations was SEK 2,816m.
http://www.sca.com
SCA’s profit before tax, excluding restructuring costs, rose 9% (12% excluding exchange rate effects) to SEK 6,218m (5,724). Net sales decreased by 2% (excluding exchange rate effects, increased by 4%) to SEK 81,578m (83,350). Profit for the period, excluding restructuring costs, rose 10% to SEK 4,601m (4,179).
http://www.sca.com
Net sales increased by 1% (4% excl exchange rate effects and divestments) to SEK 19,490m (19,231). Operating profit excl items affecting comparability rose 4% (7% excl divestments) to SEK 1,834m (1,767). Earnings per share amounted to SEK 1.73 (1.89). Cash flow from current operations was SEK 1,301m (446).
Read more on http://www.sca.com/Q12012en
Net sales rose 11% excl. exchange rate effects and divestments to SEK 85,408m (81,337). Operating profit increased to SEK 8,646m (7,738). Operating cash flow was SEK 9,644m (7,418). Earnings per share were SEK 7.06 (0.78). The Board of Directors proposes an increase in the dividend by 7.1%, to SEK 4.50 per share (4.20).
Operating profit, excluding items affecting comparability, decreased by 4% (unchanged excluding exchange rate effects) to SEK 9,224m (9,608). The Board of Directors proposes an increase in the dividend by 5%, to SEK 4.20 (4.00) per share. Net sales decreased by 1% (increased by 4% excluding exchange rate effects and divestments) to SEK 105,750m (106,965).
Read more on http://www.sca.com/Q42011en
http://www.sca.com/Q32011en SCA’s interim report for the period 1 January – 30 September 2011 has been published. Operating profit , excl. restructuring costs, decreased by 5% (decreased by 1% excl. exchange rate effects) to SEK 6,697m. Net sales decreased by 1% (increased by 6% excl. exchange rate effects and divestments) to SEK 79 001m. Earnings per share rose 2% (7% excl. exchange rate effects) to SEK 5.66.
http://www.sca.com/ir
http://www.facebook.com/SCA
http://www.twitter.com/SCAeveryday
http://www.youtube.com/SCAeveryday
Net sales decreased by 3 percent to SEK 54,374m. Profit before tax rose 12% to SEK 3,944m. Restructuring costs amounted to SEK 451m. Profit for the period rose 10% to 2,860m. Earnings per share were SEK 3.57. Cash flow from current operations was SEK 2,816m.
http://www.sca.com
Operating profit, excl. restruct. costs, decreased by 5% (increased by 1% excl. exchange rate effects) to SEK 4,262m. Net sales decreased by 2% (increased by 5% excl. exchange rate effects and divestments) to SEK 52,064m. Earnings per share rose 8% (13% excl. exchange rate effects) to SEK 3.85.
More info available on http://www.sca.com/ir
Net sales rose 15% (6% excluding exchange rate effects) to SEK 27,958m (24,234). Organic sales growth, which excludes exchange rate effects, acquisitions and divestments, was 6%. Operating profit, excluding items affecting comparability, rose 9% to SEK 2,872m (2,630).
The operating margin, excluding items affecting comparability, was 10.3% (10.9). Profit before tax, excluding items affecting comparability, rose 11% to SEK 2,602m (2,342). Items affecting comparability totaled SEK -122m (-247). Earnings per share were SEK 2.43 (2.12). Return on capital employed, excluding items affecting comparability, was 11.2% (11.0). Cash flow from current operations was SEK 1,246m (667).
http://www.sca.com/ir SCA has delivered a binding offer to acquire Georgia-Pacific´s European tissue operations, with sales in 2010 amounting to EUR 1.25bn (SEK 11.9bn). The offered price is EUR 1.32bn (SEK 12.6bn). Georgia-Pacific´s acceptance of this offer is subject to consultations with works councils where appropriate.
http://www.facebook.com/SCA
http://www.twitter.com/SCAeveryday
http://www.youtube.com/SCAeveryday
http://www.sca.com/ir SCA CFO Lennart persson held a presentation at the TMC seminar on September 22, 2011.
He talked about hygiene products sales increase, strategic focus areas, brands, market positions, innovation, growth potential for hygiene products, emerging markets, sustainability as a business driver.
http://www.facebook.com/SCA | http://www.twitter.com/SCAeveryday | http://www.youtube.com/SCAeveryday
Presentation of Jan Johansson, CEO and President, SCA at the SCA Presentation at the Handelsbanken Materials and Energy Seminar in Stockholm, Sweden on March 03, 2011.
http://www.sca.com/ir
SCA's presentation by Kersti Strandqvist, SVP Sustainability, at the Cheuvreux Climate Change 6 conference in Paris, May 6, 2011.
http://www.sca.com/sustainability
This is SCAs presentation following the interim report for Q2 2015. The second quarter of 2015 showed continued good organic sales growth and a higher operating profit compared with the same period a year ago. This is despite a continued challenging business environment, with higher raw material costs mainly owing to the stronger U.S. dollar.
SCA´s net sales for the first nine months rose 14% excluding exchange rate effects and divestments and amounted to SEK 66,577m. Operating profit rose 15% excluding items affecting comparability and exchange rate effects to SEK 6,885m (6,224).
Operating profit, excl. restruct. costs, decreased by 5% (increased by 1% excl. exchange rate effects) to SEK 4,262m. Net sales decreased by 2% (increased by 5% excl. exchange rate effects and divestments) to SEK 52,064m. Earnings per share rose 8% (13% excl. exchange rate effects) to SEK 3.85.
More info available on http://www.sca.com/ir
Net sales rose 15% (6% excluding exchange rate effects) to SEK 27,958m (24,234). Organic sales growth, which excludes exchange rate effects, acquisitions and divestments, was 6%. Operating profit, excluding items affecting comparability, rose 9% to SEK 2,872m (2,630).
The operating margin, excluding items affecting comparability, was 10.3% (10.9). Profit before tax, excluding items affecting comparability, rose 11% to SEK 2,602m (2,342). Items affecting comparability totaled SEK -122m (-247). Earnings per share were SEK 2.43 (2.12). Return on capital employed, excluding items affecting comparability, was 11.2% (11.0). Cash flow from current operations was SEK 1,246m (667).
http://www.sca.com/ir SCA has delivered a binding offer to acquire Georgia-Pacific´s European tissue operations, with sales in 2010 amounting to EUR 1.25bn (SEK 11.9bn). The offered price is EUR 1.32bn (SEK 12.6bn). Georgia-Pacific´s acceptance of this offer is subject to consultations with works councils where appropriate.
http://www.facebook.com/SCA
http://www.twitter.com/SCAeveryday
http://www.youtube.com/SCAeveryday
http://www.sca.com/ir SCA CFO Lennart persson held a presentation at the TMC seminar on September 22, 2011.
He talked about hygiene products sales increase, strategic focus areas, brands, market positions, innovation, growth potential for hygiene products, emerging markets, sustainability as a business driver.
http://www.facebook.com/SCA | http://www.twitter.com/SCAeveryday | http://www.youtube.com/SCAeveryday
Presentation of Jan Johansson, CEO and President, SCA at the SCA Presentation at the Handelsbanken Materials and Energy Seminar in Stockholm, Sweden on March 03, 2011.
http://www.sca.com/ir
SCA's presentation by Kersti Strandqvist, SVP Sustainability, at the Cheuvreux Climate Change 6 conference in Paris, May 6, 2011.
http://www.sca.com/sustainability
This is SCAs presentation following the interim report for Q2 2015. The second quarter of 2015 showed continued good organic sales growth and a higher operating profit compared with the same period a year ago. This is despite a continued challenging business environment, with higher raw material costs mainly owing to the stronger U.S. dollar.
SCA´s net sales for the first nine months rose 14% excluding exchange rate effects and divestments and amounted to SEK 66,577m. Operating profit rose 15% excluding items affecting comparability and exchange rate effects to SEK 6,885m (6,224).
Through continued focus on our strategic priorities profitable growth, innovation and efficiency, we delivered favorable organic sales and earnings growth for the first quarter of 2016.
In 2014 SCA delivered its highest profit before tax ever and good organic sales growth. We increased our operating profit, excluding items affecting comparability, by SEK 1,468m. We achieved this thanks to the continued work with our strategic priorities – growth, innovation and efficiency.
We have presented a report for the second quarter of 2014 with continued sales growth, higher earnings and a higher margin compared with the same period a year ago. During the quarter, several innovations and product launches were carried out under the Libero, Libresse, TENA and Tork brands. The efficiency programs in the hygiene and forest products operations continue to deliver cost savings according to plan. Our Tissue and Forest Products business areas showed significant earnings growth. Personal Care was negatively impacted by higher raw material costs and negative exchange rate effects in emerging markets.
The SCA interim report was published on April 29 at approximately 8.00 CET. At the subsequent press conference CEO Jan Johansson held this presentation.
This is SCAs presentation of the Year-end Report 2013. The presentation was held by CEO Jan Johansson on January 29. SCA further strengthened its position in emerging markets in 2013. During the fourth quarter of 2013, the offer for the Chinese tissue company Vinda was completed, and SCA is today the majority owner of Vinda with 51.4% ownership in the company. SCA decided during the year to invest in local production of hygiene products in India and has launched Libero baby diapers and Tempo consumer tissue in the Indian market.
The efficiency programs in the hygiene and forest products operations are continuing according to plan.
Consolidated net sales for 2013, excluding exchange rate effects and divestments, rose 10% compared with a year ago. The increase is mainly attributable to acquisitions and higher volumes. Operating profit, excluding items affecting comparability, exchange rate effects and divestments, rose 19%. Cost savings, higher volumes, the acquisition in Europe and gains on forest swaps contributed to the earnings improvement. Operating profit for Personal Care and Tissue, excluding items affecting comparability, exchange rate effects and divestments, rose 4% and 27%, respectively. Operating profit for Forest Products, excluding items affecting comparability, rose 35%. Profit before tax, excluding items affecting comparability, exchange rate effects and divestments, rose 25%.
Consolidated net sales for the fourth quarter of 2013, excluding exchange rate effects and divestments, rose 1% compared with the same period a year ago. The increase is mainly attributable to higher volumes. Operating profit, excluding items affecting comparability, exchange rate effects and divestments, rose 31%. Cost savings and gains on forest swaps contributed to the earnings improvement. The corresponding profit for Tissue rose 18%, while profit for Personal Care decreased by 12% as a result of lower earnings for baby diapers associated with an increase in marketing activities. However, incontinence care products and feminine care products had a positive earnings impact. Operating profit for Forest Products, excluding items affecting comparability, rose 188%. Profit before tax, excluding items affecting comparability, exchange rate effects and divestments, rose 38%.
Consolidated net sales for the first quarter of 2013, excluding exchange rate effects and divestments, rose 20% compared with the same period a year ago. The increase is mainly attributable to acquisitions and higher volumes.
Operating profit excluding exchange rate effects and items affecting comparability rose 25%. The corresponding profit for Personal Care and Tissue rose 27% and 40%, respectively, while profit for Forest Products decreased by 22%. Forest Products includes positive earning effects of SEK 121m attributable to land swaps and negative exchange rate effects of approximately SEK 110m. Profit before tax, excluding exchange rate effects and items affecting comparability, rose 34%. The Group’s operating cash flow improved by 5%, to approximately SEK 1.9bn.
SCA is a leading global hygiene and forest products company. The Group develops and produces sustainable personal care, tissue and forest products. Sales are conducted in about 100 countries under many strong brands. The Group has about 36,000 employees and sales in 2012 amounted to SEK 85bn (EUR 9.8bn). Read more on www.sca.com.
SCA hosted the Capital Markets Day in Stockholm. The Group-wide financial targets and strategy remains with a focus on efficiency, innovation, growth and sustainability. The target for return on capital employed for Tissue and Forest Products has been adjusted. In recent years, SCA has completed hygiene acquisitions and divested for example the packaging operations. In order to further strengthen profitability in the hygiene operations, measures are initiated for decreased costs and improved efficiency.
http://www.sca.com/ir Mats Berencreutz, Executive Vice President at SCA, hold a presentation at the Handelsbanken consumer seminar in Stockholm, December 2, 2011. The presentation focused on increased sales of hygiene products, strategic focus areas, sustainability, innovation, growth potential for hygiene products and the binding offer for Georgia Pacific’s European tissue operations.
http://www.facebook.com/SCA
http://www.twitter.com/SCAeveryday
http://www.youtube.com/SCAeveryday
2. Q3 2012
Macro update
Global economy slowing
Debt crisis in parts of Western Europe has a negative impact
Emerging markets show relatively good growth
Tissue
Good growth in emerging markets
Some growth in Western Europe and North America
Personal Care
Good growth in emerging markets
Good demand for incontinence products in Europe
Stable demand for baby diapers and feminine care in Western Europe
Forest Products
Lower European demand for publication papers
Continued weak demand for solid-wood products
Improved market balance for kraftliner
2 Interim Report Q3 2012
3. Summary
Q3 2012 vs Q3 2011
Sales increased 16%*
Hygiene business
Tissue acquisition
Higher volumes
Higher tissue prices
Strong growth in emerging markets
• Personal Care, 26%**
• Tissue, 20%**
Forest Products
Lower prices
EBIT increased 20%***
Tissue acquisition
Higher volumes
Lower raw material and energy costs
Cost savings
Strong EBIT improvement in Personal Care and Tissue
Lower EBIT in Forest Products
Operating cash flow increased 25%
* Excluding exchange rate movements and divestment
** Excluding exchange rate movements
*** Excluding items affecting comparability, exchange rate movements and divestments
3 Interim Report Q3 2012
9. Summary
Good sales growth and profitability improvement in
the hygiene business
Challenging times for Forest Products
Strong cash flow generation
Efficiency program delivering according to plan
Georgia-Pacific acquisition has developed in line
or slightly above expectations
Divestment of Aylesford Newsprint
Included in the Dow Jones Sustainability Europe
Index
Several product launches
9 Interim Report Q3 2012